NEUMORA THERAPEUTICS INC (NMRA)
US6409791000 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 275.71M | 374.04M | 240.90M | 409.20M | 192.00M | |||
| Marketable Securities | 65.59M | 79.94M | 130.90M | 0.00 | N/A | |||
| Receivables | N/A | 939.00K | 900.00K | 200.00K | 100.00K | |||
| Other Current Assets | 7.30M | 23.36M | 15.20M | 6.10M | 1.70M | |||
| Total Current Assets | 348.61M | 478.28M | 388.00M | 415.60M | 193.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.93M | 6.86M | 10.60M | 4.00M | 3.90M | |||
| Investments And Advances | 0.00 | 9.85M | 23.50M | 0.00 | N/A | |||
| Other Non-Current Assets | 0.00 | 1.21M | 4.10M | 9.70M | 200.00K | |||
| Total Non-Current Assets | 3.93M | 17.92M | 38.20M | 13.70M | 4.10M | |||
| TOTAL ASSETS | 352.54M | 496.19M | 426.20M | 429.30M | 197.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 25.50M | 24.64M | 14.90M | 20.20M | 6.40M | |||
| Accounts Payable | 6.11M | 337.00K | 7.10M | 1.60M | 2.40M | |||
| Other Current Liabilities | 133.00K | 139.00K | 1.60M | 1.50M | 600.00K | |||
| Total Current Liabilities | 31.74M | 25.11M | 23.70M | 23.30M | 9.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 55.00K | 2.01M | 5.70M | 1.40M | 1.30M | |||
| Total Non-Current Liabilities | 55.00K | 2.01M | 5.70M | 1.40M | 1.30M | |||
| TOTAL LIABILITIES | 31.80M | 27.12M | 29.40M | 24.70M | 10.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -888.40M | -703.43M | -467.50M | -336.60M | -99.30M | |||
| Additional Paid In Capital | 1.21B | 1.17B | 21.40M | 11.40M | 4.90M | |||
| Common Shares | 16.00K | 16.00K | 843.70M | 729.90M | 281.70M | |||
| Shares Outstanding | 160.48M | 158.83M | 151.90M | 151.90M | 151.90M | |||
| Tangible Book Value per Share | 2.00 | 2.95 | -2.94 | -2.14 | -0.62 | |||
| Total Shareholders' Equity | 320.74M | 469.08M | 396.80M | 404.60M | 187.30M | |||
| TOTAL LIABILITIES AND EQUITY | 352.54M | 496.19M | 426.20M | 429.30M | 197.90M | |||
| Statistics | ||||||||
| Current Ratio | 10.98 | 19.05 | 16.37 | 17.84 | 20.62 | |||
| Return On Assets (ROA) | -83.31% | -47.55% | -30.71% | -55.28% | -50.16% | |||
| Return On Equity (ROE) | -91.57% | -50.30% | -32.99% | -58.65% | -53.00% | |||
All data in USD , ROIC based on taxRate of 0.21